Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (311-320 of 632) with videos related to

Pageof 64
Sort By:
Human Immunology|September 30, 2008
Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis CTonio Wiederholt, Michael von Westernhagen, Mirko Moreno Zaldivar, et al.
Alimentary Pharmacology & Therapeutics|March 16, 2019
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C-RegistryThomas Berg, Uwe Naumann, Albrecht Stoehr, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Comparison of CT-Guided Microwave Ablation of Liver Malignancies with and Without Intra-Arterial Catheter Placement for Contrast AdministrationAnne Bettina Beeskow, Holger Gößmann, Hans-Jonas Meyer, et al.
European Journal of Gastroenterology & Hepatology|September 21, 2020
Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R)Kerstin Stein, Albrecht Stoehr, Hartwig Klinker, et al.
AIDS Research and Therapy|February 15, 2011
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?Frank Wiesmann, Jan Vachta, Robert Ehret, et al.
Journal of Hepatology|July 23, 2003
Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis CGolo Ahlenstiel, Thomas Berg, Rainer P Woitas, et al.
Antiviral Therapy|August 16, 2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapyFlorian van Bömmel, Jörg Trojan, Katja Deterding, et al.
Journal of Hepatology|October 15, 2021
Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS)Francesco Paolo Russo, Manhal Izzy, Ashwin Rammohan, et al.
Pathogens (Basel, Switzerland)|January 21, 2023
Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis BJanett Fischer, Shuang Long, Eleni Koukoulioti, et al.
Plos One|August 1, 2012
Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scoresThomas Karlas, Marie Neuschulz, Annett Oltmanns, et al.
Pageof 64

Showing results (311-320 of 632) with videos related to

Sort By:
Pageof 64
Human Immunology|September 30, 2008
Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis CTonio Wiederholt, Michael von Westernhagen, Mirko Moreno Zaldivar, et al.
Alimentary Pharmacology & Therapeutics|March 16, 2019
Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C-RegistryThomas Berg, Uwe Naumann, Albrecht Stoehr, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Comparison of CT-Guided Microwave Ablation of Liver Malignancies with and Without Intra-Arterial Catheter Placement for Contrast AdministrationAnne Bettina Beeskow, Holger Gößmann, Hans-Jonas Meyer, et al.
European Journal of Gastroenterology & Hepatology|September 21, 2020
Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R)Kerstin Stein, Albrecht Stoehr, Hartwig Klinker, et al.
AIDS Research and Therapy|February 15, 2011
The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?Frank Wiesmann, Jan Vachta, Robert Ehret, et al.
Journal of Hepatology|July 23, 2003
Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis CGolo Ahlenstiel, Thomas Berg, Rainer P Woitas, et al.
Antiviral Therapy|August 16, 2012
Evolution of adefovir-resistant HBV polymerase gene variants after switching to tenofovir disoproxil fumarate monotherapyFlorian van Bömmel, Jörg Trojan, Katja Deterding, et al.
Journal of Hepatology|October 15, 2021
Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS)Francesco Paolo Russo, Manhal Izzy, Ashwin Rammohan, et al.
Pathogens (Basel, Switzerland)|January 21, 2023
Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis BJanett Fischer, Shuang Long, Eleni Koukoulioti, et al.
Plos One|August 1, 2012
Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scoresThomas Karlas, Marie Neuschulz, Annett Oltmanns, et al.
Pageof 64